Unum Therapeutics Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Unum Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014133
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Unum Therapeutics Inc (Unum) is a cancer cell therapy company that discovers, develops, and commercializes novel antibody-coupled cellular immunotherapies. The company uses its proprietary Antibody-Coupled T-cell Receptor (ACTR) technology for discovering and developing new cellular immunotherapies for cancer. Its ACTR technology is combined with tumor-specific antibodies and directs an individual’s cytotoxic T-lymphocytes (CTLs) to activate the body’s own immune system to fight cancer. The company works in partnership with other biotechnology company to develop new combinations of ACTR T-cells and tumor targeting antibodies. Unum is headquartered in Cambridge, Massachusetts, the US.

Unum Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Unum Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Unum Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Unum Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Unum Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Unum Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Unum Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Unum Therapeutics Raises USD65 Million in Series B Financing 10
Unum Therapeutics Raises USD12 Million in Series A Venture Financing 12
Licensing Agreements 13
Seattle Genetics Enters into Licensing Agreement with Unum Therapeutics 13
Equity Offering 14
Unum Therapeutics Plans to Raise USD5 Million in Private Placement of Shares 14
Unum Therapeutics Inc – Key Competitors 15
Unum Therapeutics Inc – Key Employees 16
Unum Therapeutics Inc – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Research And Development 18
Apr 03, 2017: Unum Therapeutics to present new data on ACTR platform at AACR 2017 18
Corporate Communications 19
Feb 09, 2016: Unum Therapeutics Appoints Jorn Aldag, an Acclaimed Biotechnology Veteran and Gene Therapy Pioneer, to its Board of Directors 19
Product News 20
12/01/2016: Unum Therapeutics to Present on its Antibody-Coupled T-Cell Receptor (ACTR) Platform at the Upcoming 58th American Society of Hematology Annual Meeting 20
10/20/2016: Unum Therapeutics to Present on its Antibody-Coupled T-Cell Receptor (ACTR) Platform at the American Association for Cancer Research (AACR) Tumor Immunology and Immunotherapy 2016 Meeting 22
Product Approvals 23
Jun 20, 2016: Unum Therapeutics Announces Active Investigational New Drug Application for ACTR087 in Patients with Relapsed/Refractory B-cell Lymphoma 23
Clinical Trials 24
Jun 19, 2017: Unum Therapeutics Announces Active Investigational New Drug Application for ACTR707 in Combination with Rituximab in Patients with Relapsed/Refractory B-cell Lymphoma 24
Other Significant Developments 25
Jan 26, 2016: Unum Therapeutics Moves to New Headquarters in Cambridge, MA as It Continues to Expand and Advance its Cellular Immunotherapy Pipeline 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Unum Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Unum Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Unum Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Unum Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Unum Therapeutics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Unum Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Unum Therapeutics Raises USD65 Million in Series B Financing 10
Unum Therapeutics Raises USD12 Million in Series A Venture Financing 12
Seattle Genetics Enters into Licensing Agreement with Unum Therapeutics 13
Unum Therapeutics Plans to Raise USD5 Million in Private Placement of Shares 14
Unum Therapeutics Inc, Key Competitors 15
Unum Therapeutics Inc, Key Employees 16

★海外企業調査レポート[Unum Therapeutics Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BeyondSpring Inc (BYSI):製薬・医療:M&Aディール及び事業提携情報
    Summary BeyondSpring Inc (BeyondSpring) is a clinical stage biopharmaceutical company focused on the development of immune-oncology cancer therapies. The company offers lead compound, Plinabulin, is derived from a natural compound which holds a number of biochemical activities and provides multiple …
  • Nuance Communications Inc (NUAN):医療機器:M&Aディール及び事業提携情報
    Summary Nuance Communications Inc (Nuance) is a provider of speech and imaging solutions. The company, offers solutions such as optical character recognition (OCR), automated speech recognition, capabilities for natural language understanding, domain knowledge and implementation capabilities, dialog …
  • Bloomberg LP:企業の戦略的SWOT分析
    Bloomberg LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Electro Scientific Industries Inc (ESIO):企業の財務・戦略的SWOT分析
    Summary Electro Scientific Industries Inc (ESI) is a brand of MKS Instruments Equipment & Solutions Division, which offers laser-based manufacturing solutions. The company offers products such as flex interconnect, circuit packaging, high density interconnect, automation, scribbing and grooving, mem …
  • Kane Biotech Inc (KNE):企業の財務・戦略的SWOT分析
    Summary Kane Biotech Inc (Kane Biotech) is a developer of pharmaceutical products that prevent and remove microbial biofilms. The company uses patent protected technology based on molecular mechanisms of biofilm formation and methods for finding compounds that inhibit or disrupt biofilms. It develop …
  • JGC Corporation (1963)-エネルギー分野:企業M&A・提携分析
    Summary JGC Corporation (JGC) is an engineering contracting company. It offers engineering, procurement and construction services for various engineering contracts and projects in the areas of oil and gas development, petroleum refining, natural gas processing, petrochemicals, clean energy and power …
  • Pilot Energy Ltd (PGY):石油・ガス:M&Aディール及び事業提携情報
    Summary Pilot Energy Ltd (Pilot), formerly Rampart Energy Ltd is an oil and gas exploration and production company. The company acquires, explores and develops conventional oil and gas assets in Australia. Its projects include Australia EP416 and EP480, Australia WA-507-P, Australia WA-503-P and Aus …
  • Kroton Educacional S.A. (KROT3):企業の財務・戦略的SWOT分析
    Kroton Educacional S.A. (KROT3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Avient Corp (POL):企業の財務・戦略的SWOT分析
    Avient Corp (POL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Papyrus Australia Limited (PPY):企業の財務・戦略的SWOT分析
    Papyrus Australia Limited (PPY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Bauhaus International (Holdings) Limited (483):企業の財務・戦略的SWOT分析
    Bauhaus International (Holdings) Limited (483) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Caixa Geral de Depositos SA:企業の戦略的SWOT分析
    Caixa Geral de Depositos SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Societe Electrique de l’Our SA:企業の戦略的SWOT分析
    Societe Electrique de l'Our SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Tesla Motors, Inc.:企業の戦略・SWOT・財務情報
    Tesla Motors, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tesla Motors, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Gas Sensing Technology Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary Gas Sensing Technology Corp (Gas Sensing Technology), doing business as Welldog, a subsidiary of The Blue Sky Group Inc, is oil and gas company that provides technologies and reservoir analysis services. The company offers shale oil and gas, coal seam gas, coal mining, conventional oil and g …
  • Pareteum Corp (TEUM):企業の財務・戦略的SWOT分析
    Pareteum Corp (TEUM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Furukawa Co., Ltd.:企業の戦略・SWOT・財務情報
    Furukawa Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Furukawa Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Sanofi SA:戦略・SWOT・企業財務分析
    Sanofi SA - Strategy, SWOT and Corporate Finance Report Summary Sanofi SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • DMG America LLC:企業の戦略的SWOT分析
    DMG America LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Bharat Dynamics Limited
    Bharat Dynamics Limited - Strategy, SWOT and Corporate Finance Report Summary Bharat Dynamics Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆